Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Missouri
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in Missouri
3 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in Missouri.
Cities in Missouri
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Washington University Saint Louis, St Louis
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT04301076A Registry for People With T-cell Lymphoma
- Washington University (Data Collection Only), St Louis
RecruitingObservational study
All ages · All sexes · Updated May 20, 2026 · NCT05978141From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.